Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents

Year of Publication:

Categories of Publication:

Lay Abstract and Manuscript Citation:

Wolf J, Abzug MJ, Anosike BI, Vora SB, Waghmare A, Sue PK, Olivero RM, Oliveira CR, James SH, Morton TH, Maron GM, Young JL, Orscheln RC, Schwenk HT, Bio LL, Willis ZI, Lloyd EC, Hersh AL, Huskins CW, Soma VL, Ratner AJ, Hayes M, Downes K, Chiotos K, Grapentine SP, Wattier RL, Lamb GS, Zachariah P, Nakamura MM. Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents. J Pediatric Infect Dis Soc. 2022 May 30;11(5):177-185. doi: 10.1093/jpids/piab124. PMID: 35107571; PMCID: PMC8903349

Find publication:

DOI: 10.1093/jpids/piab124

The lay abstract for this publication was generated using an AI model and reviewed by the lead author and the PEDSnet Engagement Core team.

Scroll to Top